FTO suppresses cardiac fibrosis after myocardial infarction via m6A-mediated epigenetic modification of EPRS
Abstract Background Cardiac fibrosis is common in myocardial infarction (MI), leading to progressive cardiac dysfunction. Studies suggested that the abnormal N 6-methyladenosine (m6A) modification induced by fat mass and obesity protein (FTO) is vital in MI. However, the effects of FTO on post-infar...
Saved in:
Main Authors: | Jian Wang (Author), Yanyan Li (Author), Lijie Deng (Author), Yafang Zha (Author), Song Zhang (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2024-11-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Acupuncture at Neiguan suppresses PVCs occurring post-myocardial infarction by alleviating inflammation and fibrosis
by: Hao Hong, et al.
Published: (2022) -
Epigenetic Modification Mechanisms Involved in Inflammation and Fibrosis in Renal Pathology
by: Jose Luis Morgado-Pascual, et al.
Published: (2018) -
Thymosin β4 Protects against Cardiac Damage and Subsequent Cardiac Fibrosis in Mice with Myocardial Infarction
by: Fei Wang, et al.
Published: (2022) -
Epigenetic modification in liver fibrosis: Promising therapeutic direction with significant challenges ahead
by: Runping Liu, et al.
Published: (2024) -
Inhibition of tartrate-resistant acid phosphatase 5 can prevent cardiac fibrosis after myocardial infarction
by: Shujun Yang, et al.
Published: (2024)